Therapeutic Level for Digoxin
The therapeutic serum concentration range for digoxin is 0.5-1.0 ng/mL, with levels above 2.0 ng/mL commonly associated with toxicity. 1, 2
Recommended Therapeutic Range
The optimal therapeutic range for digoxin has been revised downward over time based on clinical evidence:
- Current guidelines recommend maintaining serum digoxin concentrations between 0.5-1.0 ng/mL 1, 2
- Retrospective analyses have shown that:
- Older therapeutic ranges (up to 2.0 ng/mL) are no longer recommended due to increased risk of adverse effects 2
Monitoring Considerations
- Serum samples should be drawn at least 6-8 hours after the last dose to ensure accurate trough levels 3
- Once-daily dosing schedules will show 10-25% lower concentrations when sampled at 24 hours versus 8 hours 3
- Regular monitoring is particularly important in:
Toxicity Risk Factors
Digoxin toxicity can occur even within the therapeutic range when certain risk factors are present:
- Serum levels >2.0 ng/mL are commonly associated with overt toxicity 1, 2
- Toxicity may occur at lower levels with:
- Drug interactions that increase digoxin levels:
Signs of Toxicity
Monitor for these signs of digoxin toxicity:
- Cardiac: arrhythmias (including bradycardia, heart block, ventricular ectopy)
- Gastrointestinal: anorexia, nausea, vomiting
- Neurological: visual disturbances (yellow-green halos), confusion, disorientation 1, 2
Special Populations
- Elderly patients (>70 years): Target lower end of therapeutic range (0.5-0.8 ng/mL) 2, 4
- Renal impairment: Lower doses required; monitor levels more frequently 2
- Patients on multiple medications: Check for potential interactions 1
Practical Implications
- Lower maintenance doses (0.125-0.25 mg daily) are typically sufficient for most patients 1
- Elderly patients, those with renal impairment, or low lean body mass should receive lower doses (0.125 mg daily or every other day) 1
- Loading doses are generally unnecessary for chronic heart failure management 1
- Digoxin should be used cautiously or avoided in post-MI patients with ongoing ischemia 1
The current evidence strongly supports maintaining lower serum digoxin concentrations (0.5-1.0 ng/mL) to maximize benefits while minimizing the risk of toxicity.